Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
Tags:
cyberattacks, cybersecurity, ransomware, Eisai, Sun Pharma, Novartis, AstraZeneca, Merck
From farm to pharma: AstraZeneca inks renewable natural gas pact to shrink environmental footprint
Fierce Pharma
Tue, 06/13/23 - 10:50 pm
Tags:
AstraZeneca, sustainability, carbon emissions
AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
MedCity News
Fri, 06/9/23 - 11:52 am
Tags:
AstraZeneca, Quell Therapeutics, type 1 diabetes, IBD, cell therapy
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
Tags:
AstraZeneca, Merck, Lynparza, NICE, UK, ovarian cancer, fallopian tube cancer
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
Tags:
EHA, AstraZeneca, Alexion, Soliris, Ultomiris, Novartis, iptacopan, PNH
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
Thu, 06/8/23 - 09:47 pm
Tags:
AstraZeneca, RSV, FDA, monoclonal antibodies, pediatric, Beyfortus
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
Tags:
ASCO 2023, oncologists, cancer, AstraZeneca, Tagrisso, non-small cell lung cancer, Novartis, Kisqali, breast cancer, Merck, Keytruda, Moderna Therapeutics, cancer vaccine
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Tags:
Sanofi, AstraZeneca, GSK, Pfizer, RSV, vaccines, FDA
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
Wed, 06/7/23 - 10:02 am
Tags:
ASCO 2023, Daiichi Sankyo, AstraZeneca, datopotamab deruxtecan, non-small cell lung cancer
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
Clinical Trials Arena
Tue, 06/6/23 - 10:06 am
Tags:
ASCO 2023, AstraZeneca, clinical trials, non-small cell lung cancer, rilvegostomig
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
BioSpace
Mon, 06/5/23 - 09:59 pm
Tags:
ASCO 2023, AstraZeneca, Tagrisso, non-small cell lung cancer
AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
Fierce Pharma
Mon, 06/5/23 - 09:55 pm
Tags:
AstraZeneca, bleeding reversal, AndexXa
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
Tags:
ASCO 2023, AstraZeneca, Enhertu, uterine cancer, cervical cancer, ovarian cancer, bladder cancer
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sun, 06/4/23 - 04:24 pm
Tags:
ASCO 2023, AstraZeneca, Lynparza, Imfinzi, ovarian cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:49 am
Tags:
AstraZeneca, Merck, Lynparza, prostate cancer, FDA
Liberate Bio taps former AZ drug-delivery head for CEO post
Medical Marketing and Media
Thu, 06/1/23 - 11:45 am
Tags:
Liberate Bio, Pharma CEOs, AstraZeneca, Shawn Davis
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
Tags:
AstraZeneca, IBD, AbbVie, JNJ, brazikumab, Skyrizi, Stelara
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
Tags:
AstraZeneca, endometrial cancer, clinical trials, Imfinzi, Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
Tags:
ASCO 2023, AstraZeneca, Imfinzi, Lynparza, endometrial cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.